WALTHAM, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker platform to potentially predict patient responses to its first-in-class targeted oncology therapies, today announced that Laura Benjamin, Ph.D., Founder and CEO of OncXerna, will participate at the upcoming virtual investor conferences:

Read more from the original source:
OncXerna Therapeutics to Participate at the Upcoming Investor Conferences

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *